Synthesis and in silico studies of hexahydroacridine derivatives as potential antitumor agents

Résumé

Abstract Despite advances in targeted cancer therapies, drug resistance and off-target toxicity remain major challenges, underscoring the need for new multi-targeted agents with improved selectivity. The present study evaluated the anticancer potential of newly synthesized hexahydro-1,8-acridinedione derivatives featuring strategic structural modifications at positions 9 and 10. The novelty of this work lies in the introduction of N -aryl substituents combined with C-9 biphenyl or 4-bromophenyl groups, a structural motif not previously reported for this chemotype. This dual modification was rationally designed to enhance π-π stacking interactions with kinase ATP-binding pockets while improving metabolic stability through fluorine substitution. Compounds were synthesized via a one-pot multicomponent reaction catalyzed by PTSA and characterized by IR, 1 H/ 13 C NMR, and LC–MS. Guided by structure-based design principles, five derivatives ( 4a, 4d, 4f., 5a, 5b ) were evaluated for cytotoxicity against HSF, H460, A431, A549, and MDA-MB-231 cell lines. Compound 4d emerged as the most potent, with an IC₅₀ of 17.91 ± 2.8 µg/mL against H460 lung cancer cells and a high selectivity index (SI = 20.7), in addition to exhibiting a considerable anti-telomerase activity. Molecular docking revealed strong binding affinities of 4d with TOP2B (− 7.02 kcal/mol), p38 MAPK (− 7.05 kcal/mol), p53 (− 7.25 kcal/mol), and EGFR (− 6.55 kcal/mol), supported by MM-GBSA binding free energies (ΔG bind ≈ − 42 kcal/mol for 4d–EGFR). Furthermore, 100-ns Molecular Dynamics simulations confirmed the stability of the 4d -EGFR complex (RMSD ≈ 1.31 Å; persistent H-bonds with CYS773/GLN767). These findings establish compound 4d as a promising multi-target lead scaffold, warranting further optimization toward selective anticancer therapeutics.

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0